Latest News
St Peter’s Fellow to lead project from new UKRI interdisciplinary scheme
11 September 2024
The University of Oxford will share in £32.4m funding from the first round of UKRI’s new cross research council responsive mode (CRCRM) pilot scheme, and St Peter’s College Fellow Professor Matthew Fuchter will lead one of the two Oxford projects selected for participation in this scheme. Announced last week, the scheme is designed to stimulate exciting new interdisciplinary research.
The interdisciplinary project led by Prof Fuchter will focus on developing new methods to realise the remarkable potential of tissue engineering. In the growing field of regenerative science and medicine, the complex regulation of human tissue development, controlled dynamically by natural chemicals called morphogens, has yet to be replicated. Through collaboration with biologists, chemists and engineers, the research aims to develop light-sensitive and biologically active morphogens to enable 3D light patterning of complex tissue.
Prof Fuchter said, ‘I am extremely excited about the potential of this project, which leverages scientific expertise developed over many years in my research group. Through the proof-of-concept data that we plan to generate in this funded work, we believe our methodology may hold much promise in the future for regenerative medicine.’
About Prof Matthew Fuchter
Prof Fuchter is the Sydney Bailey Fellow in Chemistry at St Peter’s College and Professor of Chemistry at the University of Oxford, where he leads a multidisciplinary research group. He is an expert in organic chemistry, working mostly on high-impact healthcare applications. He is the inventor of two different drugs currently undergoing clinical trials for cancer therapy, and is the Founder, Non-Executive Director and Head of Chemistry for NK:IO Ltd, an immune-oncology spinout company.